This PDF is free for all visitors!
Article May 1, 2004
Metabolic Changes Associated With Antipsychotic Use
Prim Care Companion J Clin Psychiatry 2004;6(suppl 2):8-13
Article Abstract
In the United States, the risk of type 2 diabetes is currently growing to epidemic proportions, with many physicians unaware that disorders such as schizophrenia and bipolar disorder naturally place patients at an increased risk for diabetes. Another serious concern for physicians is the development of metabolic syndrome, also known as syndrome X, in patients suffering from schizophrenia. Metabolic syndrome often encompasses medical conditions such as weight gain, hypertriglyceridemia, and increased insulin, glucose, and low-density lipoprotein cholesterol levels. Treatment with atypical antipsychotics may increase the risk of metabolic syndrome and diabetes, and physicians need to be proactive when treating patients with schizophrenia. Physicians should be aware that the treatment of schizophrenia involves the right balance for the patient in terms of adverse effects versus benefit, and failing to treat a patient’s mental illness because of potential medical problems may place the patient at an increased risk for more serious problems.
Download Free PDF
Vol 27 • 2025 • Number 3
Read the Current Issue
Original Research
Conflict Mediation by CBT
Systematic Review
Psychiatric Adverse Effects of Hydroxychloroquine
Review Article
Efficacy of GLP-1 Agonists in Mental Disorders
Rounds in the General Hospital
Time-Limited Teaching of Psychiatry to Medical Students
Rounds in the General Hospital
Multimodal Approaches to Pain Management
Rounds in the General Hospital